A further ten million Oxford-AstraZeneca vaccines have been sent
by the UK to COVAX, with ten million more due to be delivered in
the coming weeks to some of the world’s most vulnerable people.
These additional donations mean 30.6 million surplus doses of
Oxford-AstraZeneca will have been given to those in need in 2021.
Oxford-AstraZeneca is the world’s most widely used vaccine,
accounting for more than half of all COVAX deliveries. Thanks to
AstraZeneca’s commitment to the UK Government to distribute the
vaccine on a non-profit basis, 1.5 billion doses have been used
in more than 170 countries.
In 2022, the UK will donate at least 20 million more Oxford-AZ
doses. This will mean we have given half of the UK’s total order
of the vaccine to countries in need.
The UK will also donate all the 20 million Janssen doses ordered
by the Government to COVAX. Domestic need for the current booster
programme will be met through mRNA vaccines and Oxford-Astra
Zeneca, meaning the UK can donate its full Janssen order to
developing countries. Janssen aim to prioritise deliveries to
countries based on need so COVAX will receive the much-needed
vaccines as soon as they come off the production line in 2022.
Today’s announcement means that the UK has now set out how 70% of
the 100m vaccines we have pledged to share with those in need
have been or will be delivered. Providing this detail of planned
donations as early as possible will help COVAX allocate and plan
delivery of doses more effectively, ensuring vaccines get to
those that need them most.
Today at a meeting of G20 leaders in Rome the Prime Minister will
hail the importance of vaccines in allowing the world to recover
from the coronavirus pandemic. He will call on G20 leaders to do
everything in their power to increase supplies to those that need
them, either through direct donation or encouraging
pharmaceutical companies to adopt the Oxford-AstraZeneca model
which is putting people over profit.
Addressing the G20 Summit, the Prime Minister is expected
to say:
“Like a waking giant, the world economy is stirring back
to life. But the pace of recovery will depend on how quickly we
can overcome Covid.
“Our first priority as the G20 must be to press ahead
with the rapid, equitable and global distribution of
vaccines.”
At the G7 Summit in Carbis Bay, leaders agreed to work to
vaccinate the world by the end of 2022. The UK will donate 100
million surplus vaccine doses by the middle of next year to help
achieve that goal.
Surplus donations alone will not allow us to defeat the pandemic.
That is why the UK is backing the Oxford-AstraZeneca production
model while providing developing countries with the financial
support they need to obtain vaccines – giving £548 million early
on to COVAX.
The UK continues to proactively manage our vaccine supply and
does not hold a stockpile of covid vaccines. All procured,
regulated doses are either used rapidly by our domestic programme
or shared internationally with countries in need.
